Developing selective small-molecule modulators of
Cancelled Solicitation Posted
- Solicitation number
- 75N98026Q00988
- Agency
-
Office of Logisitics and Acquisition Operations
National Institutes of Health, Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- PSC
- Q301 Reference Laboratory Testing
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The National Institutes of Health, Office of Acquisitions, seeks a firm-fixed-price contract to conduct a pharmacokinetic study of compound NCGC00592266 in mice, with responses due August 24, 2026 at 8:00 AM EST. This is an unrestricted, full and open competitive acquisition for commercial services under FAR 12.603.
Place of performance is NIH/NCATS, 9808 Medical Center Drive, Rockville, Maryland 20850. The study spans September 4 through November 3, 2026 and requires intraperitoneal administration of the compound at 10 mg/kg once daily for seven consecutive days, with plasma, brain, liver, and pancreas sample collection at nine specified time points. Deliverables include blood work results, pharmacokinetic results on days 1 and 14, and results transmitted via email to specified NCATS personnel, along with biweekly conference call presentations over one month following purchase order receipt. The Government will provide the required compound. Level of effort is estimated at one PhD-level manager, one PhD-level scientist, and one week of work.
The NAICS code is 541715, Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology), with a small business size standard of 1,000 employees. The PSC code is Q301, Reference Laboratory Testing. Evaluation factors are price, technical capability, past performance, and delivery schedule. Responses must include unit and total pricing, shipping and handling costs, delivery timeframe, delivery terms, F.O.B. point, product/service description, Unique Entity Identifier, Taxpayer Identification Number, and business size certification. All offerors must be registered in SAM.gov and submit responses to Jaddua.Johnston@nih.gov.
Notice text
(i) This is a combined synopsis/solicitation for commercial items prepared in accordance with FAR Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes only solicitation; proposals are being requested, and a separate written solicitation will not be issued.
(ii) The solicitation number is 75N98026Q00988. This solicitation is issued as a competitive combined synopsis/solicitation for commercial products or commercial services. The Government intends to award a contract or purchase order resulting from this solicitation using full and open competition.
This acquisition is conducted under the authority of FAR 12.603, Streamlined Solicitation for Commercial Products or Commercial Services, and is not expected to exceed the simplified acquisition threshold (if applicable).
The National Institutes of Health (NIH), Office of the Director, Office of Acquisitions, seeks to award a (Firm-Fixed-Price) to the offeror responsible whose proposal represents the best value to the Government.
(iii) The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular effective August 7, 2026
(iv) The associated NAICS code is 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) and the small business size standard is 1000 employees.
This requirement is unrestricted.
Files
| File | Type | Posted |
|---|---|---|
| Sol_75N98026Q00988.pdf |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| Notice of Intent: Measuring AAV9 vector DNA in mice tissue using qPCR | Office of Logisitics and Acquisition Operations | No set-aside | |
| Biobanking, Laboratory Analytics, and Associated Informatics Services for NIH Biorepositories | National Institute on Drug Abuse | No set-aside | |
| NOI - A Non-Invasive Prognostic Biomarker - Circul | Office of Logisitics and Acquisition Operations | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity